BridgeMD
Tests treatment safety and results for Tinnitus
Official title The Efficacy of Repetitive Transcranial Magnetic Stimulation in Patients With Chronic Subjective Tinnitus
ClinicalTrials.gov ID: NCT06635967
What this study is testing
- What it's testing
- The aim of this study is to compare the efficacy of frequency-specific patterned repetitive transcranial magnetic stimulation (rTMS) and 1Hz rTMS for the treatment of chronic subjective tinnitus. In this single-blind randomized controlled study, patients will be randomly assigned 1:1 to receive two different types of rTMS stimulation.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Adults aged between 18 and 80 years old.
- Experiencing persistant subjective tinnitus for at least 3 months.
- A score of 38 or more on THI.
- 50 dB HL or less on the average pure tone threshold (0.5, 1, 2kHz) of the worse ear.
- Voluntarily participate in the study and sign the informed consent form.
You likely can't join if
- Diagnosis of Meniere's disease, conductive hearing loss or objective tinnitus.
- History of epilepsy or stroke.
- Diagnosis of acoustic neuroma.
- Severe sensorineural hearing loss.
- Surgically or traumatically implanted ferromagnetic foreign bodies, including but not limited to pacemakers, neurostimulators, prosthetic metal heart...
- Patients with active metal foreign bodies (metal implants, dentures, contraceptive rings), insulin pumps, etc., who have been evaluated in detail and...
See the full eligibility criteria
- Adults aged between 18 and 80 years old.
- Experiencing persistant subjective tinnitus for at least 3 months.
- A score of 38 or more on THI.
- 50 dB HL or less on the average pure tone threshold (0.5, 1, 2kHz) of the worse ear.
- Voluntarily participate in the study and sign the informed consent form.
- Have normal mental status and cognitive function, and be able to cooperate with the research process.
- Diagnosis of Meniere's disease, conductive hearing loss or objective tinnitus.
- History of epilepsy or stroke.
- Diagnosis of acoustic neuroma.
- Severe sensorineural hearing loss.
- Surgically or traumatically implanted ferromagnetic foreign bodies, including but not limited to pacemakers, neurostimulators, prosthetic metal heart valves, aneurysm clips (non-titanium alloy), intraocular metal...
- Patients with active metal foreign bodies (metal implants, dentures, contraceptive rings), insulin pumps, etc., who have been evaluated in detail and are at risk for rTMS treatment.
- Patients taking vestibular sedatives, antipsychotics, anxiolytics, antiepileptics, and ototoxic drugs.
- Patients with a recent history of alcohol or drug abuse
- Bell's palsy
- Acute ear infection within the last 1 month
- Inability to cooperate or complete the study process
- Participation in another clinical trial within the last month.
- Have any condition that may affect compliance or safety
- Any other condition that, in the opinion of the investigator, makes enrollment in the study inappropriate.
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, Shanghai Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, Shanghai Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.